[en] The acute hemodynamic effects of intravenous diltiazem were studied in 8 patients with coronary artery disease, left ventricular (LV) failure (New York Heart Association functional class III), a rest ejection fraction (EF) less than 40% or a cardiac index less than 2.4 liters/min/m2. Hemodynamic measurements and LV angiograms were performed at rest before and after the administration of diltiazem, 0.5 mg/kg, administered at a speed of 5 mg/min. Diltiazem treatment induced a decrease in heart rate from 68 +/- 12 to 55 +/- 9 beats/min (p less than 0.001). Mean aortic pressure decreased from 94 +/- 14 to 81 +/- 15 mmHg (p less than 0.05). Thus, the pressure-rate product significantly decreased under the influence of the drug, from 8,791 +/- 2,465 to 6,342 +/- 1,808 beats mm Hg/min, (p less than 0.001). Diltiazem induced no significant change of LV end-diastolic pressure, pulmonary wedge pressure, cardiac index and LV stroke work index. Systemic vascular resistance decreased (p less than 0.01), whereas pulmonary vascular resistance showed no change. End-systolic volume diminished (p less than 0.02), which accounts for the increase of stroke volume and ejection fraction (p less than 0.001). Disorders of regional contractility were not aggravated by diltiazem, and even improved in individual cases. Thus, intravenous diltiazem may be used safely in patients with heart failure. However, in view of the marked bradycardic effects seen in some cases, heart rate should be carefully monitored.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Materne, P.
Legrand, Victor ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie
Vandormael, M.
Collignon, P.
Kulbertus, Henri ; Université de Liège - ULiège > Relations académiques et scientifiques (Médecine)
Language :
English
Title :
Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
Low, Takeda, Lee, Mason, Awan, DeMaria (1981) Effects of diltiazem-induced calcium blockade upon exercise capacity in effort angina due to chronic coronary artery disease. American Heart Journal 101:713-718.
Hossack, Bruce (1981) Improved exercise performance in persons with stable angina pectoris receiving diltiazem. Am J Cardiol 47:95-101.
Hossack, Bruce, Ritterman, Kusumi, Trimble (1982) Divergent effects of diltiazem in patients with exertional angina. Am J Cardiol 49:538-546.
Hossack, Pool, Steele, Crawford, DeMaria, Cohen, Poros (1982) Efficacy of diltiazem in angina on effort: a multicenter trial. Am J Cardiol 49:567-572.
Kolwaya, Nakamura, Mitsutake, Tanaka, Tereshita (1981) Increased exercise tolerance after oral diltiazem a calcium antagonist in angina pectoris. American Heart Journal 101:143-149.
Strauss, McIntyre, Parisi, Shapiro (1982) Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial. Am J Cardiol 49:560-566.
De Backer, Vincke (1982) Double-blind comparison of diltiazem and placebo in the treatment of exercise-inducible chronic stable angina pectoris. Acta Cardiol 37:245-255.
Hung, Lamb, Connoly, Dutzy, Goris, Schroeder (1983) The effect of diltiazem and propranolol alone and in combination on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized and placebo-controlled study. Circulation 68:560-567.
Legrand, Hastir, Vandormael, Collignon, Kulbertus (1984) Hemodynamic effects of intravenous diltiazem at rest and exercise in patients with coronary artery disease. Eur Heart J 5:456-463.
Feldman, Pepine, Wittle (1982) Short and long-term responses to diltiazem in patients with variant angina. Am J Cardiol 49:554-559.
Rosenthal, Ginsburg, Lamb, Balm, Schroeder (1980) Efficacy of diltiazem for control of symptoms of coronary arterial spasm. Am J Cardiol 46:1027-1032.
Maeda, Takasugi, Tsukano, Shiota (1981) Clinical study on the hypotensive effect of diltiazem hydrochloride. Int J Clin Pharmacol Ther Toxicol 19:47-55.
Crevey, Dantzker, Bower, Popat, Walker (1982) Hemodynamic and gas exchange effects of intravenous diltiazem in patients with pulmonary hypertension. Am J Cardiol 49:578-583.
Nagao, Omote, Hyon, Horie, Tanaka (1981) Diltiazem-induced decrease of exercise elevated pulmonary arterial diastolic pressure in hypertrophic cardiomyopathy patient. Am Heart J 102:789-790.
Yeh, Kov, Lin, Hung, Wu (1983) Effects of oral diltiazem in paroxysmal supraventricular tachycardia. Am J Cardiol 52:271-278.
Fleckenstein (1971) Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention of production of myocardial lesions. Calcium and the Heart , P Harris, LH Opie, Academic Press, New York; 135-188.
Brauwald (1982) Mechanisms of action of calcium-channel-blocking agents. New England Journal of Medicine 307:1618-1627.
Low, Takeda, Mason, DeMaria (1982) The effects of calcium channel blocking agents on cardiovascular function. Am J Cardiol 49:547-553.
Ingels, Daughters, Stinson, Alderman (1980) Evaluation of methods of quantitative left ventricular segments wall motion in man using myocardial markers as a standard. Circulation 61:966-972.
Mulling, Leshin, Miersziak, Alsobrook, Mitchell (1972) Changes in left ventricular function produced by the injection of contrast media. American Heart Journal 83:373-381.
Hamby, Aintablian, Wilsoff, Harstein (1977) Effects of contrast medium on left ventricular pressure and volume with emphasis on coronary artery disease. Am Heart J 93:9-18.
Fischer, Thomson (1978) Contrast media in coronary arteriography. A review. Invest Radiol 13:450-459.
Rovel, Mitchard, Morselli (1978) Single, sensitive and specific gas chromatographic method for the quantification of diltiazem in human body fluids. J Chromatogr 41:52-59.
Henry (1980) Comparative pharmacology of calcium antagonists: nifedipine, verapamil, and diltiazem. Am J Cardiol 46:1047-1058.
Fleckenstein (1977) Specific pharmacology of calcium in myocardium, cardiac pace-makers and vascular smooth muscle. Annu Rev Pharmacol 17:149-166.
Lathrop, Valle-Aguilera, Millard, Gaum, Hannon, Francis, Nakaya, Schwartz (1982) Comparative electrophysiologic and coronary hemodynamic effects of diltiazem nisoldipine and verapamil on myocardial tissue. The American Journal of Cardiology 49:612-620.
Matsui, Murakami, Takekoshi (1979) Hemodynamic effects of sublingual nifedipine in congestive heart failure. Jpn Circ J 43:1081-1088.
Matsumoto, Ito, Sada, Takahashi, Su, Veda, Okabe, Sato, Sekine, Ito (1980) Hemodynamic effects of nifedipine in congestive heart failure. Am J Cardiol 46:476-480.
Polese, Florentini, Olivari, Guazzi (1979) Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. Am J Med 66:825-830.
Chew, Hecht, Collet, McAllister, Singh (1981) Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J Cardiol 47:917-922.
Singh, Roche (1977) Effects of intravenous verapamil on hemodynamics in patients with heart disease. Am Heart J 94:593-599.
Lewis, Mitha, Gotsman (1975) Immediate hemodynamic effects of verapamil in man. Cardiology 60:366-376.
Ferlinz, Citron (1983) Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure. Am J Cardiol 51:1339-1345.
Bourassa, Cote, Theroux, Tubau, Genain, Waters (1980) Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans. Chest 78:224-230.
Levine, Francis, Goldsmith, Cohn (1983) The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure. Circulation 67:1070-1079.
Mason (1969) Usefulness and limitations of the rate of rise of intraventricular pressure (dP/dt) in the evaluation of myocardial contractility in man. Am J Cardiol 23:516-527.
Bache, Dymek (1982) Effect of diltiazem on myocardial blood flow. Circulation 65:I.
Kenny, Daly, Bergman, Kerkez, Jackson, Dewitt (1982) Haemodynamic and metabolic effects of diltiazem, a new calcium antagonist, compared with nifedipine in patients with coronary artery disease. (abstr). Br Heart J 48:89.
Gross, Warltier, Hardman (1981) Differential effects of slow channel calcium blockers and classical arteriolar vasodilators on true coronary collateral perfusion (abstr). Circulation 64:IV-281.